COVID-19 Patients, Hospital Staff Burdened by DEA Quotas
Coronavirus patients on ventilators are feeling the pinch of federal drug quotas.
Drugs & Medical Devices
Indivior Offers $600 Million to Settle Justice Department Investigation
Suboxone film drugmaker settles federal probe finding it misrepresented the drug’s benefits.
FDA Will Now Require Naloxone Info on Opioid Labels
The Food and Drug Administration requires Narcan information to be present on the labels of prescription opioids.
Opioid Task Force Requests Barrier Removal for Addiction Treatment
The American Medical Association Opioid Task Force believes barriers need to be removed for evidence-based treatments.
Experts Suggest Sacklers Could Get Their Bankruptcy Settlement
Legal experts suggest the Sacklers may just get their way after all.
Act Aims to Get Medicare on Board with Opioid Alternatives
The Non-Opioids Prevent Addiction in the Nation Act aims to get Medicare to cover safe pain alternatives.
HHS Rolls Out New COVID-19 Database to Replace CDC’s System
The HHS has rolled out a new coronavirus tracking database meant to replace the CDC’s system.
Pennsylvania County Files Civil Suit Against Opioid Companies
Chester County, Pennsylvania files a lawsuit against opioid manufacturers and distributors.
Alabama Moves to Ban Tianeptine, an Opioid-like Antidepressant
Alabama plans to ban an antidepressant commonly sold at convenience stores and online because of its opioid-like effects.
NY Announces Additional Addiction Treatment Cuts Amid COVID-19
New York’s addiction treatment centers are forced to take additional budget cuts during the pandemic.